These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29239130)

  • 1. Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals.
    Simmons R; Ireland G; Irving W; Hickman M; Sabin C; Ijaz S; Ramsay M; Lattimore S; Mandal S
    J Viral Hepat; 2018 May; 25(5):482-490. PubMed ID: 29239130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the hepatitis C cascade of care in people attending drug treatment services in England: A data linkage study.
    Ireland G; Simmons R; Hickman M; Eastwood B; Ramsay M; Mandal S
    Int J Drug Policy; 2019 Oct; 72():55-60. PubMed ID: 31257040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England.
    Harrison GI; Murray K; Gore R; Lee P; Sreedharan A; Richardson P; Hughes AJ; Wiselka M; Gelson W; Unitt E; Ratcliff K; Orton A; Trinder K; Simpson C; Ryder SD; Oelbaum S; Foster GR; Christian A; Smith S; Thomson BJ; Reynolds R; Harris M; Hickman M; Irving WL
    Addiction; 2019 Jun; 114(6):1113-1122. PubMed ID: 30694582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
    Hariri S; Sharafi H; Sheikh M; Merat S; Hashemi F; Azimian F; Tamadoni B; Ramazani R; Gouya MM; Abbasi B; Tashakorian M; Alasvand R; Alavian SM; Poustchi H; Malekzadeh R
    Harm Reduct J; 2020 Oct; 17(1):80. PubMed ID: 33081794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015.
    Roberson JL; Lagasca AM; Kan VL
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):148-155. PubMed ID: 28974107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.
    Kim NJ; Locke CJ; Park H; Magee C; Bacchetti P; Khalili M
    J Gen Intern Med; 2019 Oct; 34(10):2005-2013. PubMed ID: 30238404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.
    Amele S; Peters L; Sluzhynska M; Yakovlev A; Scherrer A; Domingo P; Gerstoft J; Viard JP; Gisinger M; Flisiak R; Bhaghani S; Ristola M; Leen C; Jablonowska E; Wandeler G; Stellbrink H; Falconer K; D'Arminio Monforte A; Horban A; Rockstroh JK; Lundgren JD; Mocroft A;
    HIV Med; 2019 Apr; 20(4):264-273. PubMed ID: 30734998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.
    Meyer JP; Moghimi Y; Marcus R; Lim JK; Litwin AH; Altice FL
    Int J Drug Policy; 2015 Oct; 26(10):922-35. PubMed ID: 26077144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study.
    Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT;
    J Viral Hepat; 2019 Jan; 26(1):83-92. PubMed ID: 30267593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet Count Improvement after Chronic Hepatitis C Treatment among Cirrhotic Patients Who Achieved Sustained Virological Response: Realworld Results from 2186 Patients in Egypt.
    Badawi R; Soliman S; Aboali L; Elkadeem M; Elfert A; Elguindy AMA; Ullah MS; Abd-Elsalam S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1300-1305. PubMed ID: 32940191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
    Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
    Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.
    Cramp ME; Rosenberg WM; Ryder SD; Blach S; Parkes J
    BMC Gastroenterol; 2014 Aug; 14():137. PubMed ID: 25100159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
    Supanan R; Han WM; Harnpariphan W; Ueaphongsukkit T; Ubolyam S; Sophonphan J; Tangkijvanich P; Thanprasertsuk S; Avihingsanon A;
    J Acquir Immune Defic Syndr; 2021 Dec; 88(5):465-469. PubMed ID: 34757974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long.
    Brouard C; Pillonel J; Boussac M; de Lédinghen V; Rachas A; Silvain C; Lydié N; Chevaliez S; Pioche C; Durand J; Lot F; Delarocque-Astagneau E
    BMC Infect Dis; 2020 Oct; 20(1):759. PubMed ID: 33059617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
    Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
    Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.
    Wade AJ; McCormack A; Roder C; McDonald K; Davies M; Scott N; Wardrop M; Athan E; Hellard ME
    J Viral Hepat; 2018 Sep; 25(9):1089-1098. PubMed ID: 29660212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.